To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.
MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities
Another incremental step forward in one of MindMed's leading psychedelics R&D initiatives.
Mind Cure Announces Non-Brokered Private Placement of up to $3 Million
Mind Cure Health is seeking to raise $3 million via the sale of 6.66 million units.
New Psychedelic Stocks: The Menu Is Getting Longer For Investors
Three new psychedelic stocks are trading publicly. One commenced trading last week, two more are coming this week.
COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care
Compass joins an international organization dedicated to advancing psychedelic drug research.
Entheon Biomedical Corp. (formerly MPV Exploration Inc.) Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange
Entheon Biomedical has announced that it expects to commence public trading on or about November 12th, symbol "ENBI".
Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services
Field Trip plans to enters Oregon's medicinal market for psilocybin-assisted psychotherapy.
Pure Extracts Technologies Corp. Commences Trading on the Canadian Securities Exchange (CSE)
Pure Extracts is now trading under the symbol "PULL".
Cybin Completes Reverse Take-Over Transaction
Cybin Corp has completed its RTO and received approval to commence trading on the NEO Exchange (symbol "CYBN") and expects to begin trading on or about November 10th.
What Oregon Psilocybin Legalization Means For The Psychedelic Drug Industry
Oregon has legalized the medicinal use of psilocybin. Here is why that's big news for the psychedelic drug industry.
Psychedelics Revolution Front-and-Center As Americans Prepare To Vote
On the eve of the U.S. election, psychedelic drugs are a high-profile election issue.
Pure Extracts Technologies Corp. to Commence Trading on the Canadian Securities Exchange (CSE)
Pure Extracts Corp. is an extraction specialist targeting the cannabis, psychedelics and functional mushrooms sectors and will trade on the CSE under the symbol "PULL".